Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-10 Sale |
2025-01-13 4:06 pm |
FATE THERAPEUTICS INC | FATE | Bressi Jerome Charles See Remarks |
5,980 | $1.55 | $9,269 | 270,203 (Direct) |
View |
| 2025-01-10 Sale |
2025-01-13 4:05 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
5,654 | $1.55 | $8,764 | 336,707 (Direct) |
View |
| 2025-01-10 Sale |
2025-01-13 4:04 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram President and CEO |
8,705 | $1.54 | $13,406 | 349,364 (Direct) |
View |
| 2024-12-20 Purchase |
2024-12-26 9:00 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
397,964 | $1.68 | $668,580 | 20,950,829 (Indirect) |
View |
| 2024-12-20 Sale |
2024-12-26 9:00 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
341,633 | $1.68 | $573,943 | 20,950,829 (Indirect) |
View |
| 2024-08-06 Sale |
2024-08-07 4:01 pm |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
633 | $4.23 | $2,678 | 8,669 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-05 4:24 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
2,447 | $7.77 | $19,013 | 101,479 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-30 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,849 | $5 | $9,245 | 103,926 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:30 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
10,874 | $4.37 | $47,519 | 142,361 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:30 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
11,271 | $4.38 | $49,367 | 158,069 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:29 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
14,391 | $4.37 | $62,889 | 371,248 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:29 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
7,028 | $4.37 | $30,712 | 105,775 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:03 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
5,182 | $3.66 | $18,966 | 112,803 (Direct) |
View |
| 2023-12-26 Purchase |
2023-12-28 9:30 pm |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
44,630 | $3.72 | $166,024 | 16,491,128 (Indirect) |
View |
| 2023-12-18 Sale |
2023-12-19 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,585 | $3.5 | $5,548 | 117,985 (Direct) |
View |
| 2023-11-09 Sale |
2023-11-13 4:01 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
24,363 | $2.4 | $58,471 | 153,235 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 4:02 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
4,718 | $2.8 | $13,210 | 119,570 (Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 4:01 pm |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
632 | $3.71 | $2,345 | 9,302 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-16 Option Award |
2025-01-16 6:36 pm |
N/A 2035-01-15 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram President and CEO |
1,300,000 | $0 | 1,300,000 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-16 6:32 pm |
N/A 2035-01-14 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
345,000 | $0 | 681,707 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-16 6:31 pm |
N/A 2035-01-14 |
FATE THERAPEUTICS INC | FATE | Bressi Jerome Charles See Remarks |
315,000 | $0 | 585,203 (Direct) |
View |
| 2024-12-20 Other |
2024-12-26 9:00 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
1,141,267 | $1.68 | 20,950,829 (Indirect) |
View |
| 2024-12-20 Other |
2024-12-26 9:00 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
232,522 | $8.4 | 20,950,829 (Indirect) |
View |
| 2024-12-12 Conversion |
2024-12-16 9:00 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
36,132 | $0 | 15,583,032 (Indirect) |
View |
Ownership |
2024-08-21 4:26 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Bressi Jerome Charles See Remarks |
0 | $0 | 1,235,636 (Direct) |
View |
| 2024-07-29 Option Award |
2024-07-31 6:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
200,000 | $0 | 358,069 (Direct) |
View |
| 2024-07-29 Option Award |
2024-07-31 6:01 pm |
N/A 2034-07-29 |
FATE THERAPEUTICS INC | FATE | Mozaffarian Neelufar Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2024-07-29 Option Award |
2024-07-31 6:00 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
200,000 | $0 | 342,361 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 6:20 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | Lee Michael Stewart Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 6:19 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:35 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:30 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:29 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:28 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:28 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:28 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:27 pm |
N/A 2034-06-07 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 9:30 pm |
2024-03-21 N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
3,636,364 | $5.499 | 3,893,674 (Indirect) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
425,000 | $0 | 425,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:09 pm |
N/A 2034-01-31 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:09 pm |
N/A 2034-01-31 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-12-26 Other |
2023-12-28 9:30 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
1,655,370 | $3.72 | 16,491,128 (Indirect) |
View |